Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy

Valentina Foglizzo1, Serena Marchiò2,3

  • 1Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Cancers
|May 28, 2022
PubMed

Insights

Nanoparticle formulations offer targeted cancer therapy, selectively killing malignant cells while sparing healthy ones. This review explores nanoparticle characteristics, drug delivery, overcoming resistance, and their role in cancer vaccines for immunotherapy.

Area of Science:

  • Oncology
  • Nanotechnology
  • Immunotherapy

Background:

  • Cancer arises from genetic alterations leading to uncontrolled cell growth.
  • Conventional chemotherapy causes significant side effects due to non-specific cellular toxicity.
  • Targeted cancer therapies aim to selectively eliminate cancer cells, preserving normal tissues.

Purpose of the Study:

  • To review recent advancements in nanoparticle formulations for cancer therapy.
  • To analyze how nanoparticle properties and targeting strategies optimize drug delivery.
  • To discuss the potential of nanoparticles in overcoming multidrug resistance and developing cancer vaccines.

Main Methods:

  • Review of current literature on nanoparticle characteristics and applications in cancer treatment.
  • Analysis of physical properties, functionalization, and therapeutic payloads of nanoparticles.
  • Exploration of nanoparticle-based strategies for drug delivery, overcoming multidrug resistance, and immunotherapy.

Main Results:

  • Nanoparticles can be engineered with specific physical properties and targeting moieties for optimized drug delivery.
  • Nanoparticle formulations can overcome multidrug resistance by combining therapies and targeting agents.
  • Nanoparticle-based cancer vaccines represent a promising frontier in cancer immunotherapy.

Conclusions:

  • Nanoparticle technology holds significant potential for developing more effective and less toxic cancer treatments.
  • Targeted delivery and combination therapies using nanoparticles can improve treatment outcomes.
  • Nanoparticle-based cancer vaccines are emerging as powerful tools for cancer immunotherapy.